Role of Free Fatty Acids in Endothelial Dysfunction
Overview
Affiliations
Plasma free fatty acids levels are increased in subjects with obesity and type 2 diabetes, playing detrimental roles in the pathogenesis of atherosclerosis and cardiovascular diseases. Increasing evidence showing that dysfunction of the vascular endothelium, the inner lining of the blood vessels, is the key player in the pathogenesis of atherosclerosis. In this review, we aimed to summarize the roles and the underlying mechanisms using the evidence collected from clinical and experimental studies about free fatty acid-mediated endothelial dysfunction. Because of the multifaceted roles of plasma free fatty acids in mediating endothelial dysfunction, elevated free fatty acid level is now considered as an important link in the onset of endothelial dysfunction due to metabolic syndromes such as diabetes and obesity. Free fatty acid-mediated endothelial dysfunction involves several mechanisms including impaired insulin signaling and nitric oxide production, oxidative stress, inflammation and the activation of the renin-angiotensin system and apoptosis in the endothelial cells. Therefore, targeting the signaling pathways involved in free fatty acid-induced endothelial dysfunction could serve as a preventive approach to protect against the occurrence of endothelial dysfunction and the subsequent complications such as atherosclerosis.
Zheng Z, Wang Y, Xie J, Chen Z, Jiang B, Xu Y PeerJ. 2025; 13:e18839.
PMID: 39950045 PMC: 11823655. DOI: 10.7717/peerj.18839.
The Role of Serum Free Fatty Acids in Endothelium-Dependent Microvascular Function.
Sullivan A, Courvan M, Ada A, Wasserman D, Niswender K, Shardelow E Endocrinol Diabetes Metab. 2025; 8(2):e70031.
PMID: 39888728 PMC: 11784902. DOI: 10.1002/edm2.70031.
The interplay of factors in metabolic syndrome: understanding its roots and complexity.
Islam M, Wei P, Suzauddula M, Nime I, Feroz F, Acharjee M Mol Med. 2024; 30(1):279.
PMID: 39731011 PMC: 11673706. DOI: 10.1186/s10020-024-01019-y.
Liu X, Gong M, Wu N Front Endocrinol (Lausanne). 2024; 15:1503704.
PMID: 39713052 PMC: 11658973. DOI: 10.3389/fendo.2024.1503704.
Jalali S, Zareshahi N, Behnoush A, Azarboo A, Shirinezhad A, Hosseini S Reprod Biol Endocrinol. 2024; 22(1):148.
PMID: 39563412 PMC: 11574999. DOI: 10.1186/s12958-024-01317-4.